Type 1 Diabetes
Type 1 diabetes, or formerly known as juvenile diabetes, is a lifelong chronic illness which occurs if the body’s own immune system starts to attack and destroy the insulin-producing beta cells of the pancreas. Once a person has been diagnosed with type 1 diabetes, they must make a number of lifestyle changes in order to keep themselves healthy. Blood glucose levels are checked multiple times a day with a series of finger pricks, daily physical activity and food intake needs to be carefully monitored, and insulin must be administered through an injection or an insulin pump device.
Type 1 diabetes used to be referred to as juvenile diabetes due to the majority of cases being diagnosed in children and young adults, but this disease can still strike at any age. Many cases of type 1 diabetes can lead to other life-threatening complications, such as heart disease, kidney failure, and even blindness. Unfortunately with a majority of cases diagnosed at such a young age, this tends to increase their lifetime risk of additional complications and years lost. Clinical research trials on type 1 diabetes are helping to advance the understanding, treatment, and prevention of this disease and further complications.
Medical researchers now know that in order to cure someone with diabetes, there are two fundamental aspects of this illness that need to be corrected. First and foremost, they need to develop a way to stop the immune system’s misguided assault on the body’s insulin-producing beta cells. Also, if new beta cells could be protected from this ongoing attack, a process which is referred to as encapsulation, this could restore the body’s insulin independence. The next step for medical researchers would be developing a way to restore the body’s ability to produce its own insulin. Currently, they know that this restoration of healthy insulin-producing cells in the body could be realized through two methods. First would be through a process of regeneration, where new cells could be made from the other remaining healthy cells in the pancreas. The other method would be manufacturing these cells in a lab or obtaining them from some other animals and then putting them into the patient’s body.
We still have a little ways to go until these treatments are available, but medical researchers have a goal and know where they are going. Currently, researchers have been identifying new therapies at a rapidly improving pace. These therapies are being tested in type 1 diabetes clinical studies with a variety of different patients. Through these diabetes clinical studies, we are developing new prevention and treatment strategies which will help improve the lives of many people with diabetes.
New technology has also been most pivotal in the recent advancements in diabetes research. We now have continuous glucose monitors, which help diabetes patients to achieve that optimal glucose control and lower their chances of future complications. Patients no longer need to prick their fingers as many times daily, and there is a lower risk of dangerous low blood glucose reactions. Medical researchers envision a final product which would combine the insulin pump with the continuous glucose monitor. It is theorized that this would lead to even greater control and reduce the stress associated with the constant monitoring of food intake, insulin administration, and physical activity.
Clinical trial facilities around the United States are working together to conduct clinical studies on type 1 diabetes. Islet transplantation is being developed as a possible cure for type 1 diabetes. This is a colossal undertaking, which has taken a collaborative effort from multiple facilities and thousands of participants from all around the nation. Researchers are utilizing brand new medical technology to test experimental therapies which could effectively prevent further life-threatening complications for diabetes patients.
At Avail Clinical Research, we are currently conducting a wide array of clinical studies targeted towards certain conditions. Our medical researchers are looking for qualified participants to take part in one of our type 1 diabetes or type 2 diabetes clinical studies. Through these clinical studies, we will continue to develop better methods of diabetes treatment and prevention. You may be eligible to participate in our current type 1 diabetes clinical trial. As a participant, there is no cost to you at any point during the study and health insurance is not required. Browse our clinical trials being conducted now to find the study best suited for you.